Subscribe
Sign In
|
Subscribe
C. Medrano
Author Archive
2025
Dec 23, 2025
FDA’s Streamlined Framework for Biosims/Interchangeability
Modern analytic tools allow the FDA to evaluate biosimilars with precision that makes the older “interchangeability” distinction unnecessary.